A Study to Evaluate the Efficacy and Safety of Gemigliptin With in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Gemigliptin 50mg;   Drug: Gemigliptin Placebo Sponsor:   LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials